Enliven Therapeutics, Inc. (ELVN): 10-Q filed Aug 5, 2026

Form type

10-Q

Filing date

Aug 5, 2026

Accession number

0001193125-26-335155

Filer

Enliven Therapeutics, Inc. (CIK 1672619)